Gateway Discovery Grant to Address Cancer Disparities in Clinical Trials

Gateway For Cancer Research is a non-profit organisation that funds clinical trials for all types of cancers. The organisation runs the Gateway Discovery Grant to provide funding for a Phase I or Phase II treatment based clinical trial that has the potential to make an impact on patient care and advance clinical practice standards. Funding will support innovative cancer researchers poised to advance clinical practice standards in areas of unmet need. The opportunity runs every two years and each grant has a different focus area.

Proposals in the second round of funding should focus on innovative clinical research with a strong potential impact on mitigating cancer health disparities. The Phase I or Phase II clinical trial may include the study of any cancer type and must propose research that will contribute to the improved diagnosis and/or treatment of cancers found to disproportionately affect underrepresented populations. Work should specifically aim to reduce disparities related to factors such as:

Race and ethnicity.





Other socioeconomic indicators that may impact outcomes.

Proposals should identify and address system-level barriers and factors contributing to disparities in clinical trials and the delivery of care for all people with cancer. Applications may be submitted by entities around the world that engage in cancer research, including:

Higher Education Institutions.

University Medical Centres.

Non-profits other than HEIs.

Government Organisations (may include medical centres and hospitals that have access to resources and infrastructure to support a research project).

Multi-institutional collaboration is encouraged. Gateway funded trials must involve patient advocates, and the team should include at least one young investigator (such as clinical research fellow; junior faculty member) that should play a key role in the project. Other collaborators are also welcomed.

The grant provides $1.5 million towards the direct costs of the research over a three to five year period. Grants will be awarded from 1 July 2022 to 30 June 2027

Letters of Intent must be submitted by the 15 March 2021 deadline.

More information about this research funding opportunity and the application process is available on the RESEARCHconnect funding information platform. RESEARCHconnect provides up-to-the minute content, insight and analysis on research funding news and policy. To find out more about how RESEARCHconnect can keep you in the know, and subscription fees, contact us today.